WE

Wellington Partners (Digital Health selective)

VC
Munich, GermanyWebsite
How to approach: warm intro preferred
Stage

Series A

Check Size

$500K – $1.0M

Portfolio

11+ companies

Team

14 partners

Investor activity
Investments in last 12 months: 0

Investment Thesis

European life science investor with selective digital health/medtech investments grounded in clinical value and scalable adoption.

Meet the Team

JM

James Myhill

Vice President, Business Development

AI

Ahmed Ismail

Vice President of Relationship Management

JL

Julia Lagemann

Vice President of Client Services

GG

Gino George

Head of Institutional Business

JG

Jeff George

Managing Director

TS

Terry Simpson

Assistant Vice President

CS

Christian Streit

Partner

MedTech
Digital Health
WL

William Lockhart

Managing Director

MC

Molly Conway

Managing Director

DR

Dr. Rainer Strohmenger

Managing Partner

KH

Kalyani Harar

Director of Private Investments

DV

Dr. Varun Gupta

Partner

DR

Dr. Regina Hodits

Venture Advisor

KW

Kai Wohlberedt

Associate

Industry Focus

Invests In

Other
Healthcare
EdTech

Portfolio Companies (11)

Other

PO

Polaris Quantum Biotech (example mix)

Life Sciences
AM

AMBOSS

Digital Health·Early-stage

"Discovered via perplexity (medium confidence)"

Medical knowledge platform for clinicians with AI-driven learning and diagnostics tools.

SI

Sidekick Health

Digital Health·Series A

"Discovered via perplexity (medium confidence)"

Nordic digital therapeutics company delivering personalized health interventions via app.

KO

Koa Health

Digital Health·Growth

"Discovered via perplexity (medium confidence)"

Digital mental health platform offering accessible treatment solutions.

ON

ONWARD Medical

Medical Devices·Growth-stage

"Discovered via perplexity (medium confidence)"

Develops implantable stimulation therapies for spinal cord injury mobility.

IM

Immatics

Life Sciences

TCR-based immunotherapies for cancer treatment.

DU

Dunad

Therapeutics·Early-stage

"Discovered via perplexity (medium confidence)"

Precision antibiotics targeting bacterial cell walls.

SP

SphingoTec

Diagnostics·Growth

"Discovered via perplexity (medium confidence)"

Biomarkers for cardiorenal and sepsis diagnostics.

QU

Quanta

Medical Devices·Expansion

"Discovered via perplexity (medium confidence)"

Dialysis systems for home and clinic use.

MI

MinervaX

Therapeutics·Clinical-stage

"Discovered via perplexity (medium confidence)"

Maternal vaccines against Group B Streptococcus.

Browse More Investors

Frequently Asked Questions

See if Wellington Partners (Digital Health selective) is a match for your startup

Upload your pitch deck to see how well you match with Wellington Partners (Digital Health selective) and 200+ other VC firms.